Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.

The funding market, moving in real timeBook a DemoChoose your plan
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Executive ChangeItem 5.02 · 8-KMEDIUM RiskPositive

Oscar Health, Inc.

Filed: May 29, 2026CIK: 0001568651
Watch CompanyView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Mario Schlosser, Oscar Health's President of Technology and CTO, is transitioning to Co-Founder & Advisor to the CEO effective June 1, 2026, while remaining on the Board. This strategic shift aims to accelerate the company's focus on artificial intelligence and digital health innovation.

Key Takeaways

Mario Schlosser transitions from CTO/President of Technology to Co-Founder & Advisor role, signaling a strategic pivot toward AI and digital health

Schlosser retains Board membership, maintaining significant influence over company direction and strategy

2 more takeaways

Related Filings (2)

2 more filings from Oscar Health, Inc. in the last 90 days

Filing Overview

Form Type8-K
Filing DateMay 29, 2026
Item5.02
CategoryExecutive Change
CIK0001568651
Accession #oscr-20260529
Risk LevelMEDIUM
SentimentPositive
Signalopportunity
Topics
leadership transitionai technology

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings